Toggle navigation
Leadership in clinical care
HOME
CE
TOPICS
Case Reports
Coding
Contact Lenses & Solutions
Cornea
Diagnostics
Dry Eye
Eyelids
Glaucoma
Low Vision
Neuro-ophthalmic Disorders
News
Ophthalmic Lenses & Dispensary
Optometric Study Center
Pharmaceuticals
Practice Management
Products
Retina
Surgery
Systemic Disease
Technology
Multimedia
Web Exclusives
EVENTS
CE Programs
Educational Programs (Non-CE)
JOBS
Tarsus Pharmaceuticals
First Prescription Treatment for Demodex Blepharitis Approved
In clinical trials, Xdemvy was able to significantly reduce or eradicate mite infestation in six weeks and showed some improvement within 15 days.
07/25/2023
LOAD MORE
Current Issue
Table of Contents
Read Digital Edition
Read PDF Edition
Archive
Subscriptions
×
Full Image